التفاصيل البيبلوغرافية
| العنوان: |
Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects. |
| المؤلفون: |
Israel, Samuel1 (AUTHOR), Kumar, Ashish2 (AUTHOR), DeAngelis, Kiernan3 (AUTHOR), Aurivillius, Magnus4 (AUTHOR), Dorinsky, Paul1,5 (AUTHOR) paul.dorinsky1@astrazeneca.com, Roche, Nicolas6 (AUTHOR), Usmani, Omar S.7 (AUTHOR) |
| المصدر: |
European Journal of Pharmaceutical Sciences. Oct2020, Vol. 153, pN.PAG-N.PAG. 1p. |
| مصطلحات موضوعية: |
*METERED-dose inhalers, *INHALERS, *RADIONUCLIDE imaging |
| مستخلص: |
This gamma scintigraphy imaging study assessed pulmonary, extrathoracic and regional lung deposition patterns of a radiolabelled inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β 2 -agonist triple fixed-dose combination budesonide/glycopyrronium/formoterol fumarate dihydrate (BGF 320/14.4/10 μg), delivered by pressurised metered dose inhaler (pMDI) using innovative co-suspension delivery technology (Aerosphere™). In this Phase I, randomised, single-centre, single-dose, two-period, crossover study (NCT03740373), 10 healthy male adults received two actuations of BGF MDI (160/7.2/4.8 μg per actuation) radiolabelled with 99mTc, not exceeding 5 MBq per actuation. Immediately following each inhalation, subjects performed a 10- or 3-second breath-hold, then exhaled into an exhalation filter. The primary objective was to assess the pulmonary deposition of BGF MDI following the 10-second breath-hold. The secondary objectives were to assess deposition after the 3-second breath-hold and lung regional and extrathoracic deposition after each breath-hold length. Imaging of the lungs, stomach, head and neck was recorded by gamma scintigraphy immediately after exhalation. The mean BGF MDI emitted dose deposited in the lungs was 37.7% for the 10-second breath-hold and 34.5% for the 3-second breath-hold. Emitted dose detected in the exhalation filter was ≤0.4% for both breath-hold lengths. The mean normalised peripheral/central ratio was 0.65 and 0.75 for the 10- and 3-second breath-holds, respectively, while the standardised central/peripheral ratios were 1.79 and 1.40, respectively. There were no new or unexpected safety findings. In conclusion, BGF MDI was efficiently deposited in the central and the peripheral regions of the lungs, with similar regional deposition patterns following a 10- and 3-second breath-hold. Image, graphical abstract [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
